Amin Adibi

Amin Adibi, Mohsen Sadatsafavi

Since 2019, medical societies have reconsidered race-specific clinical equations often in parallel to and largely independent from algorithmic fairness research. Focusing on lung function reference algorithms that affect medical care, insurance, and employment for hundreds of millions globally, we analyze the transition from race-specific GLI-2012 to race-averaged GLI-Global through a fairness lens. Drawing on historical context, citation analysis, and quantitative evaluation, we show (i) limited cross-citation between FAccT and clinical guideline revision efforts; (ii) that GLI-Global implicitly encodes assumptions about social determinants of health, behaving as if ~62% of the Black-White gap in FEV1 is exposure-related; and (iii) clinical validation studies operationalized a sufficiency-like fairness criterion long before its formalization in fairness literature, while neglecting foundational results such as the impossibility theorem has led to inefficiencies in clinical research. Overall, our analysis highlights the value of deeper, mutually beneficial engagement between medical and fairness communities and the public to accelerate progress toward equitable healthcare algorithms.

Amin Adibi, Xu Cao, Zongliang Ji et al.

The fourth Machine Learning for Health (ML4H) symposium was held in person on December 15th and 16th, 2024, in the traditional, ancestral, and unceded territories of the Musqueam, Squamish, and Tsleil-Waututh Nations in Vancouver, British Columbia, Canada. The symposium included research roundtable sessions to foster discussions between participants and senior researchers on timely and relevant topics for the ML4H community. The organization of the research roundtables at the conference involved 13 senior and 27 junior chairs across 13 tables. Each roundtable session included an invited senior chair (with substantial experience in the field), junior chairs (responsible for facilitating the discussion), and attendees from diverse backgrounds with an interest in the session's topic.

Balagopal Unnikrishnan, Ariel Guerra Adames, Amin Adibi et al. · harvard, mit

While ethical arguments for fairness in healthcare AI are well-established, the economic and strategic value of inclusive design remains underexplored. This perspective introduces the ``inclusive innovation dividend'' -- the counterintuitive principle that solutions engineered for diverse, constrained use cases generate superior economic returns in broader markets. Drawing from assistive technologies that evolved into billion-dollar mainstream industries, we demonstrate how inclusive healthcare AI development creates business value beyond compliance requirements. We identify four mechanisms through which inclusive innovation drives returns: (1) market expansion via geographic scalability and trust acceleration; (2) risk mitigation through reduced remediation costs and litigation exposure; (3) performance dividends from superior generalization and reduced technical debt, and (4) competitive advantages in talent acquisition and clinical adoption. We present the Healthcare AI Inclusive Innovation Framework (HAIIF), a practical scoring system that enables organizations to evaluate AI investments based on their potential to capture these benefits. HAIIF provides structured guidance for resource allocation, transforming fairness and inclusivity from regulatory checkboxes into sources of strategic differentiation. Our findings suggest that organizations investing incrementally in inclusive design can achieve expanded market reach and sustained competitive advantages, while those treating these considerations as overhead face compounding disadvantages as network effects and data advantages accrue to early movers.